Buscar resultados de ensayos clínicos
Isolated Growth Hormone Deficiency - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD) Condición: Adult Growth Hormone Deficiency Fecha: 2013-03-05 Intervenciones: Drug: Saizen® solution for injection (referred as Saizen®) Saizen® solution for injection |
Completed |
Nombre del estudio: Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency Condición: Growth Hormone Deficiency Fecha: 2010-01-29 Intervenciones:
|
Completed |
Nombre del estudio: Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON Condición: Growth Hormone Deficiency Fecha: 2011-06-01 Intervenciones: Other: Growth hormone Drug given by prescription |
Completed |
Nombre del estudio: A Study of Zomacton in Children With Growth Hormone Deficiency Condición: Growth Hormone Deficiency Fecha: 2009-04-17 Intervenciones:
|
Withdrawn |
Nombre del estudio: Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton® Condición: Growth Hormone Deficiency Fecha: 2012-11-16 Intervenciones: Drug: Somatropin Somatropin powder and solvent for solution for injection |
Active, not recruiting |
Nombre del estudio: 304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency Condición: Growth Hormone Deficiency Fecha: 2006-08-08 Intervenciones: Drug: growth hormone (Nutropin) growth hormone (Nutropin), 0.3mg/kg/week administered subcutaneously dai |
Recruiting |
Nombre del estudio: A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency Condición: Growth Hormone Deficiency Fecha: 2017-04-05 Intervenciones: Drug: Somavaratan All subjects will receive somavaratan 3.5 mg/kg twice monthly (every 15 days ± 2 |
Recruiting |
Nombre del estudio: Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency Condición: Growth Hormone Deficiency Fecha: 2016-09-19 Intervenciones: Drug: PEG-somatropin High dose group: PEG Somatropin 0.2 mg/kg/w, subcutaneous use, inject once a week, |
Completed |
Nombre del estudio: Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency Condición: Growth Hormone Deficiency Fecha: 2016-01-19 Intervenciones:
|
Terminated |
Nombre del estudio: Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD) Condición: Growth Hormone Deficiency Fecha: 2015-03-30 Intervenciones:
|